SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950124-03-003514
Filing Date
2003-11-10
Accepted
2003-11-10 15:47:57
Documents
7
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR PERIOD END SEPTEMBER 30, 2003 k80604e10vq.htm 10-Q 248631
3 2000 EQUITY COMPENSATION PLAN k80604exv10w59.txt EX-10.59 46613
4 LOAN AND SECURITY AGREEMENT k80604exv10w60.txt EX-10.60 55282
5 SECTION 302 CERTIFICATION OF CEO k80604exv31w1.htm EX-31.1 4199
6 SECTION 302 CERTIFICATION OF CFO k80604exv31w2.htm EX-31.2 4211
7 SECTION 906 CERTIFICATION OF CEO k80604exv32w1.htm EX-32.1 1465
8 SECTION 906 CERTIFICATION OF CFO k80604exv32w2.htm EX-32.2 1477
  Complete submission text file 0000950124-03-003514.txt   364247
Mailing Address 3621 STATE STREET 695 KMS PLACE ANN ARBOR MI 48108
Business Address 3621 S STATE STREET 695KMS PLACE 734-332-0506 ANN ARBOR MI 48108
ESPERION THERAPEUTICS INC/MI (Filer) CIK: 0001066745 (see all company filings)

IRS No.: 383419139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16033 | Film No.: 03988366
SIC: 2834 Pharmaceutical Preparations